Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Heijtink

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Journal of Medical Virology|February 1, 1989
Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routesR A Heijtink, R M Knol, S W Schalm
Journal of Medical Virology|May 1, 1985
Detection of integration during active replication of hepatitis B virus in the liverP J Boender, S W Schalm, R A Heijtink
Nederlands Tijdschrift Voor Geneeskunde|August 30, 1997
[Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum]P Vrijmoeth, R A Heijtink, H Schreuder, et al.
European Journal of Clinical Investigation|April 1, 1979
Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitisW Weimar, R A Heijtink, S W Schalm, et al.
Antiviral Research|January 1, 1985
Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccineR A Heijtink, J Kruining, M Bakker, et al.
Journal of Virological Methods|April 1, 1985
Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine studyR A Heijtink, J Kruining, S W Schalm, et al.
Vaccine|July 20, 2002
Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliableR A Heijtink, P M Schneeberger, B Postma, et al.
Medical Microbiology and Immunology|January 1, 1980
Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferonR A Heijtink, N Masurel, W Weimar, et al.
Journal of Medical Virology|January 1, 1982
Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?R A Heijtink, J van Hattum, S W Schalm, et al.
Hepatology (Baltimore, Md.)|July 1, 1984
Hepatitis B vaccination in Down's syndrome and other mentally retarded patientsR A Heijtink, P De Jong, S W Schalm, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Journal of Medical Virology|February 1, 1989
Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routesR A Heijtink, R M Knol, S W Schalm
Journal of Medical Virology|May 1, 1985
Detection of integration during active replication of hepatitis B virus in the liverP J Boender, S W Schalm, R A Heijtink
Nederlands Tijdschrift Voor Geneeskunde|August 30, 1997
[Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum]P Vrijmoeth, R A Heijtink, H Schreuder, et al.
European Journal of Clinical Investigation|April 1, 1979
Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitisW Weimar, R A Heijtink, S W Schalm, et al.
Antiviral Research|January 1, 1985
Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccineR A Heijtink, J Kruining, M Bakker, et al.
Journal of Virological Methods|April 1, 1985
Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine studyR A Heijtink, J Kruining, S W Schalm, et al.
Vaccine|July 20, 2002
Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliableR A Heijtink, P M Schneeberger, B Postma, et al.
Medical Microbiology and Immunology|January 1, 1980
Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferonR A Heijtink, N Masurel, W Weimar, et al.
Journal of Medical Virology|January 1, 1982
Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?R A Heijtink, J van Hattum, S W Schalm, et al.
Hepatology (Baltimore, Md.)|July 1, 1984
Hepatitis B vaccination in Down's syndrome and other mentally retarded patientsR A Heijtink, P De Jong, S W Schalm, et al.
Pageof 9